| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |